US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist

1.3000
0.00000.00%

Trading Nov 4 15:13 ET

2.73MMarket Cap-75P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-66.72%2.33M

-47.84%3.23M

-59.85%3.03M

-11.99%4.45M

28.48%7.01M

6.43%6.19M

12.93%7.54M

149,847.93%5.06M

-Cash and cash equivalents

-66.72%2.33M

-47.84%3.23M

-59.85%3.03M

-11.99%4.45M

28.48%7.01M

6.43%6.19M

12.93%7.54M

149,847.93%5.06M

Prepaid assets

40.01%861.4K

2.77%611.94K

-25.68%711.19K

269.54%523.76K

201.06%615.24K

113.32%595.43K

--956.93K

--141.73K

Total current assets

-58.11%3.19M

-43.40%3.84M

-56.00%3.74M

-4.32%4.98M

34.71%7.62M

11.32%6.78M

27.26%8.5M

9,826.85%5.2M

Non current assets

Total non current assets

--0

Total assets

-58.11%3.19M

-43.40%3.84M

-56.00%3.74M

-4.32%4.98M

34.71%7.62M

11.32%6.78M

27.26%8.5M

9,826.85%5.2M

Liabilities

Current liabilities

Payables

--231.87K

--146.19K

244.19%360.66K

----

--104.79K

----

-accounts payable

--231.87K

--146.19K

244.19%360.66K

----

--104.79K

----

Current accrued expenses

--0

----

Current deferred liabilities

--44.98K

----

--0

----

--783.68K

----

Other current liabilities

-96.83%7.66K

-98.94%18.44K

-71.63%470.74K

--80.51K

--241.16K

--1.73M

--1.66M

----

Current liabilities

-85.26%284.51K

-95.90%164.63K

-67.37%831.4K

48.00%1.18M

2,632.68%1.93M

7,204.93%4.01M

2,450.25%2.55M

-94.73%799.48K

Non current liabilities

Total non current liabilities

--0

Total liabilities

-85.26%284.51K

-95.90%164.63K

-67.37%831.4K

48.00%1.18M

2,632.68%1.93M

7,204.93%4.01M

2,450.25%2.55M

-94.73%799.48K

Shareholders'equity

Share capital

-58.05%1.32K

-93.92%1.02K

734.38%534

-69.71%3.14K

61.36%16.7K

-99.38%64

-15.67%10.35K

-common stock

-58.05%1.32K

-93.92%1.02K

734.38%534

-69.71%3.14K

61.36%16.7K

-99.38%64

-15.67%10.35K

-Preferred stock

--0

Retained earnings

-6.61%-82.56M

-8.07%-81.77M

-12.44%-80.91M

-8.93%-79.36M

-8.10%-77.44M

-6.33%-75.67M

-2.11%-71.96M

-3.64%-72.85M

Paid-in capital

2.81%85.47M

8.96%85.45M

7.58%83.81M

7.64%83.15M

7.66%83.13M

1.60%78.43M

1.13%77.91M

40.04%77.24M

Total stockholders'equity

-48.90%2.91M

32.55%3.67M

-51.13%2.91M

-13.82%3.79M

1.87%5.69M

-54.09%2.77M

-9.55%5.95M

129.10%4.4M

Total equity

-48.90%2.91M

32.55%3.67M

-51.13%2.91M

-13.82%3.79M

1.87%5.69M

-54.09%2.77M

-9.55%5.95M

129.10%4.4M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-66.72%2.33M	-47.84%3.23M	-59.85%3.03M	-59.85%3.03M	-11.99%4.45M	28.48%7.01M	6.43%6.19M	12.93%7.54M	12.93%7.54M	149,847.93%5.06M
-Cash and cash equivalents	-66.72%2.33M	-47.84%3.23M	-59.85%3.03M	-59.85%3.03M	-11.99%4.45M	28.48%7.01M	6.43%6.19M	12.93%7.54M	12.93%7.54M	149,847.93%5.06M
Prepaid assets	40.01%861.4K	2.77%611.94K	-25.68%711.19K	-25.68%711.19K	269.54%523.76K	201.06%615.24K	113.32%595.43K	--956.93K	--956.93K	--141.73K
Total current assets	-58.11%3.19M	-43.40%3.84M	-56.00%3.74M	-56.00%3.74M	-4.32%4.98M	34.71%7.62M	11.32%6.78M	27.26%8.5M	27.26%8.5M	9,826.85%5.2M
Non current assets
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-58.11%3.19M	-43.40%3.84M	-56.00%3.74M	-56.00%3.74M	-4.32%4.98M	34.71%7.62M	11.32%6.78M	27.26%8.5M	27.26%8.5M	9,826.85%5.2M
Liabilities
Current liabilities
Payables	--231.87K	--146.19K	244.19%360.66K	244.19%360.66K	----	----	----	--104.79K	--104.79K	----
-accounts payable	--231.87K	--146.19K	244.19%360.66K	244.19%360.66K	----	----	----	--104.79K	--104.79K	----
Current accrued expenses	--0	----	----	----	----	----	----	----	----	----
Current deferred liabilities	--44.98K	----	--0	--0	----	----	----	--783.68K	--783.68K	----
Other current liabilities	-96.83%7.66K	-98.94%18.44K	-71.63%470.74K	-71.63%470.74K	--80.51K	--241.16K	--1.73M	--1.66M	--1.66M	----
Current liabilities	-85.26%284.51K	-95.90%164.63K	-67.37%831.4K	-67.37%831.4K	48.00%1.18M	2,632.68%1.93M	7,204.93%4.01M	2,450.25%2.55M	2,450.25%2.55M	-94.73%799.48K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-85.26%284.51K	-95.90%164.63K	-67.37%831.4K	-67.37%831.4K	48.00%1.18M	2,632.68%1.93M	7,204.93%4.01M	2,450.25%2.55M	2,450.25%2.55M	-94.73%799.48K
Shareholders'equity
Share capital	-58.05%1.32K	-93.92%1.02K	734.38%534	734.38%534	-69.71%3.14K	-69.71%3.14K	61.36%16.7K	-99.38%64	-99.38%64	-15.67%10.35K
-common stock	-58.05%1.32K	-93.92%1.02K	734.38%534	734.38%534	-69.71%3.14K	-69.71%3.14K	61.36%16.7K	-99.38%64	-99.38%64	-15.67%10.35K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-6.61%-82.56M	-8.07%-81.77M	-12.44%-80.91M	-12.44%-80.91M	-8.93%-79.36M	-8.10%-77.44M	-6.33%-75.67M	-2.11%-71.96M	-2.11%-71.96M	-3.64%-72.85M
Paid-in capital	2.81%85.47M	8.96%85.45M	7.58%83.81M	7.58%83.81M	7.64%83.15M	7.66%83.13M	1.60%78.43M	1.13%77.91M	1.13%77.91M	40.04%77.24M
Total stockholders'equity	-48.90%2.91M	32.55%3.67M	-51.13%2.91M	-51.13%2.91M	-13.82%3.79M	1.87%5.69M	-54.09%2.77M	-9.55%5.95M	-9.55%5.95M	129.10%4.4M
Total equity	-48.90%2.91M	32.55%3.67M	-51.13%2.91M	-51.13%2.91M	-13.82%3.79M	1.87%5.69M	-54.09%2.77M	-9.55%5.95M	-9.55%5.95M	129.10%4.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data